EW
Eugene Williams
Director

Eugene Williams insider trades: ProMIS Neurosciences (PMN) stock purchases

Director, ProMIS Neurosciences Last trade Nov 4, 2026 12 Form 4 filings
$0
Sold, last 12 months
0 sales
$237K
Bought, last 12 months
4 buys
9
Open-market trades
since 2022
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Eugene reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 4, 2026PMN↑ Buy$91K
Oct 30, 2026PMN↑ Buy$5K
Mar 5, 2026PMN↑ Buy$49K
Mar 4, 2026PMN↑ Buy$92K
Dec 16, 2022PMN↑ Buy$9K
Dec 12, 2022PMN↑ Buy$5K
Dec 7, 2022PMN↑ Buy$5K
Dec 2, 2022PMN↑ Buy$6K
Jul 11, 2022PMN↑ Buy$10K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other PMN insiders

Open-market trades in the last 12 months

About Eugene Williams's insider trades

Eugene Williams is a director at ProMIS Neurosciences (PMN). Since Jul 11, 2022, Eugene has reported 9 open-market purchases worth $273K and no sales on SEC Form 4. In the last 12 months: 4 buys ($237K).

Their filings also include grants and awards (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PMN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.